moreNOTICE
- ● CPHI China 2024
- ● ANKEBIO's TRASTUZUMAB
- ● Virus Killer: Interferon ɑ2b
- ● ANTI COVID-19 PRODUCTS
- ● CPhI China 2020
- ● ANKEBIO Video
- ● CPhI China 2019
- ● New packing for ANSOMONE is on the market now
- ● AnkeBio Wins the National Invention Patent
- ● The unique official website for genuine HGH/ANSOMONE? is www.xianztehotel.cn
- ● CPhI China 2018
- ● CPhI China 2017
We, Anhui Anke Biotechnology (Group) Co., Ltd., professional and comprehensive in developing, producing and marketing pharmaceuticals concerning genetic engineering products,diagnostic products,precision medicine, polypeptide APIs, biochemistry and traditional Chinese medicines,staffed with abount qualified and creative R&D team and equipped with first-class facilities, certified by GMP and ISO9001.
Our parent company is located in China Hefei New and High Technology Development Area. As based on high-efficient Research & Development Center, we, AnkeBio always keep up with international development and have been undertaken with 10 subjects such as "National 863 Projects", National scientific and technological project, National key Torch Program and Scientific and Technological Projects, key scientific and technological specialties of Anhui province and Natural Fund Project and etc. and have developed nearly 10 National Novel Drugs in recent years.
Our dominant products, Recombinant Human Growth Hormone (Ansomone?), Series of Recombinant Human Interferon alpha 2b (Anterferon?), MAR Kit for Anti-sperm Antibody and etc., are all developed independently. These products have more and more significant therapeutically effect on clinical testing and application of many kinds of intractable disease such as chronic hepatitis B, tumor, leukemia, nutritional support burned wound and immunopurification sterility and etc.
Our subsidiary companies like Anhui Anke Yuliangqing Pharmaceutical Co., Ltd., Anhui Anke Hengyi Pharmaceutical Co., Ltd. and Anhui Anke Yuliangqing Pharmaceutical Co., Ltd have been established from recombination of Anqing Yuliangqing Pharmaceutical Co., Ltd.,Tongling NO.1 Pharmaceutical Company dominated by Anke biotechnology Co.,Ltd. since year 2000.The products are extended from biomedical products into modern Chinese herb medicines and synthetic medicines.
The sales networks of our products have covered more than 30 provinces in China. More than 40 Regional Offices of AnkeBio have built up in the whole China and the international Co-operation has developed quickly.
The mission of AnkeBio is discovering, developing, manufacturing and marketing health-care products with Higher Quality as well as Best Services to improving life quality of human.
